Siste oppdatering :
22/08/2024
Cytoprotektiva   Dexrazoxane hydrochloride  
Injeksjon
Oppløsningsstabilitet Stabilitet i blandinger Faktorer som påvirker stabiliteten Kompatibilitet Administrasjonsmåte Referanser pdf
   Kjemisk struktur  

Handelsnavn   Handelsnavn     

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Cardioxane Brasil, Chile, Danmark, Ecuador, Frankrike, Irland, Italia, Mexico, Peru, Polen, Spania, Storbritannia, Tyskland, Ungarn, Venezuela, Østerrike
Cyrdanax Frankrike, Tyskland
Dexrazoxane Ecuador, USA
Dexrazoxano Mexico, Peru
Razox Peru
Razoxane Colombia
Rhianta Mexico
Savene Belgia, Danmark, Finland, Frankrike, Hellas, Irland, Italia, Nederland, Norge, Polen, Romania, Spania, Storbritannia, Sverige, Tyskland, Ungarn
Zinecard Canada, USA
Zucordex Mexico
Referanser   Injeksjon   Referanser : Dexrazoxane hydrochloride  
Type publikasjon
381 Journal Beijnen JH, Van Gijn R.
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
J Parenter Sci Technol 1993 ; 47: 166-171.
1423 Journal Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1754 Journal Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1949 Journal Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH.
Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies.
Clinical Cancer Research 2001 ; 7: 1569-1576.
1953 Journal Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
2201 Journal Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B.
Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers.
EJHP Science 2007 ; 13, 3: 55-59.
2224 Journal Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P.
Dexrazoxane: Stabilià in soluzione.
Bolletino SIFO 2007 ; 53: 178-180.
3581 Labratorium Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit
Clinigen Healthcare 2013
3611 Journal Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T.
Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions.
J Oncol Pharm Practice 2014 ; 20, 1: 58-64.

  Mentions Légales